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ABSTRACT The Src homology 2 (SH2) and collagen domain protein Shc plays a pivotal role in signaling via tyrosine kinase
receptors, including epidermal growth factor receptor (EGFR). Shc binding to phospho-tyrosine residues on activated receptors
is mediated by the SH2 and phospho-tyrosine binding (PTB) domains. Subsequent phosphorylation on Tyr-317 within the Shc
linker region induces Shc interactions with Grb2-Son of Sevenless that initiate Ras-mitogen-activated protein kinase signaling.
We use molecular dynamics simulations of full-length Shc to examine how Tyr-317 phosphorylation controls Shc conformation
and interactions with EGFR. Our simulations reveal that Shc tyrosine phosphorylation results in a signiﬁcant rearrangement of
the relative position of its domains, suggesting a key conformational change. Importantly, computational estimations of binding
afﬁnities show that EGFR-derived phosphotyrosyl peptides bind with signiﬁcantly more strength to unphosphorylated than to
phosphorylated Shc. Our results unveil what we believe is a novel structural phenomenon, i.e., tyrosine phosphorylation of
Shc within its linker region regulates the binding afﬁnity of SH2 and PTB domains for phosphorylated Shc partners, with important
implications for signaling dynamics.INTRODUCTION
Adaptor proteins with multiple interaction domains transmit
signals from receptor tyrosine kinases (RTKs) and other
cell-surface receptors, initiating numerous signaling path-
ways (1). One of these adaptors is the Src homology 2
(SH2) and collagen domain protein (Shc) that plays a key
role in the initiation of the mitogen-activated protein kinase
(MAPK) cascade, regulating cell survival, proliferation, and
differentiation (2,3). Shc consists of the N-terminal phospho-
tyrosine-binding (PTB) and C-terminal SH2 domains, which
recognize specific phosphotyrosine sites on RTKs and other
signaling proteins, such as protein phosphatase 2A (4,5) and
the central collagen-homology (CH) linker region (6). Acti-
vated RTKs, including epidermal growth factor receptor
(EGFR), phosphorylate Shc on Tyr-317 within the CH
region. Tyr-317 is a major site for binding the growth factor
receptor binding protein 2 (Grb2) adaptor and the Grb2-SOS
(Son of Sevenless) complex, which triggers Ras activation
(7–9).
Regulatory adaptor proteins, such as Shc, are often re-
garded much the same way as adaptors for plug-and-play
devices. These proteins have a number of modular interac-
tion domains that are organized as ‘‘beads on a string’’ and
that recognize specific sequence motifs. At first glance, the
Shc modular structure implies that the phosphorylation of
residues located outside the specialized binding domains
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motions of these domains to impact binding to phospho-
tyrosines on Shc-specific partners. In a previous study, we
derived a theoretical model structure of full-length Shc
(Protein Data Bank (PDB) identification, 1WCP; Fig. 1),
and investigated the dynamic properties of both phosphory-
lated Shc (pY317-Shc) and unphosphorylated Shc (Y317-
Shc), using short-timescale (2-ns) molecular dynamics
(MD) simulations (10). We found that Tyr-317 phosphoryla-
tion increases Shc structural rigidity and reduces coupling of
domain motions between the PTB and SH2 domains, which
might alter the Shc binding affinity for phosphorylated RTKs
(10).
Here, we exploit long-timescale (10-ns) MD simulations
to analyze the impact of Shc phosphorylation on EGFR-
Shc interactions pivotal for the activation of downstream
MAPK signaling. Both the PTB and SH2 domains of Shc
bind to phosphorylation sites with well-characterized
consensus sequences on various RTKs, including EGFR
(4). Based on NMR data and homology modeling, we
construct model docked structures of the full-length Y317-
Shc and pY317-Shc molecules with the EGFR-derived phos-
photyrosyl (pY) peptides, corresponding to known sites of
Shc binding to EGFR. Several computational techniques to
estimate binding free energies of protein-protein or protein-
ligand associations were proposed, such as the free energy
perturbation (FEP) method (11), molecular mechanics-Pois-
son/Boltzmann surface area (MM-PBSA) calculations (12),
and the linear interaction energy (LIE) method (13–17).
doi: 10.1016/j.bpj.2008.11.018
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calculate the binding free energies (and affinities expressed
in terms of KD values) of the full-length Y317-Shc and
pY317-Shc with each EGFR-derived pY-peptide. We further
justify the results of the LIE method by performing thermo-
dynamic integration (TI) simulations of Y317-Shc binding to
one of the EGFR-derived pY-peptides. The results for the
relative binding free energies from the more rigorous TI
simulations match closely with those obtained from the
LIE method, justifying the LIE results. Our simulation
results revealed that the critical rearrangement of the relative
positions of Shc domains induced by Tyr-317 phosphoryla-
tion significantly reduces the binding affinities of pY317-Shc
for EGFR-derived pY-peptides.
What we believe to be a novel structural phenomenon was
revealed by our computational results, i.e., tyrosine phos-
phorylation of Shc in the linker region bridging two recogni-
tion domains dramatically changes the Shc binding function.
The calculations imply that this linker-region phosphoryla-
tion operates as a molecular switch, causing the disengage-
ment of the Shc adaptor from EGFR. Disruption of the
EGFR-Shc complex leads to only transient protection of
EGFR against phosphatase activities, and to a transient
time course of receptor phosphorylation in response to
a constant (growth-factor) stimulus (18). Our findings
change the current paradigm of interactions between multi-
domain proteins, and help assess the functional conse-
quences of signaling events resulting in the phosphorylation
of individual residues.
METHODS
System setup
We used our theoretical model structure of Y317-Shc (PDB identification,
1WCP; p52 isoform of human Shc) (10) to specify the initial coordinates
in MD simulations of full-length Y317-Shc molecules. The theoretical struc-
ture of the p52 isoform of human Shc (PDB identification, 1WCP) was
modeled using two experimentally determined structures of the PTB and
SH2 domains of Shc (PDB accession codes, 1shc and 1tce, respectively).
We mapped the target sequence of p52 Shc onto those modeling templates,
using integrated sequence tools and structural superposition algorithms of
FIGURE 1 Ribbon diagram of theoretical model structure of Shc. Color
assignment corresponds to (A) secondary structures (magenta, a-helix;
yellow, b-sheet; cyan, turn; and gray, random structure) and (B) Shc domains
(red, SH2 domain; gray, CH domain; and blue, PTB domain). In B, Tyr-317
is highlighted by a space-fill model (green).the DeepView (Swiss-PdbViewer) program. Then the sequence alignment
was optimized manually and submitted to the Swiss-model server for model
building. The resulting protein model (residues 17–474) was improved by
performing a 5000-step energy minimization in vacuum, using the molecular
operating environment (MOE) program (Chemical Computing Group,
Montreal, Quebec, Canada). The final theoretical model structure of the
p52 isoform of human Shc was deposited into the PDB (PDB identification,
1WCP). During the deposition of Shc coordinates to the PDB, a rigorous
validation of the structure by PROCHECK1 was performed, which included
the collection of structural diagnostics such as bond distance and angle
comparisons, torsion-angle comparisons, and molecular graphic images.
For MD simulations involving pY317-Shc, the initial structure was ob-
tained by replacing Tyr-317 in the CH region with pTyr, followed by mini-
mizing the energy of the system by treating only the side-chain atoms of the
pTyr-317 residue as flexible. To neutralize the net charge of the simulation
system, counterions (Naþ) were added by using the Leap module in the
Amber program package, and the protonation state of all charged residues
was set, based on a pH of 7.0. All initial structures were placed at the center
of the water sphere in which the water molecules were modeled using the
TIP3P 3-point charge model potential (19). The size of the water sphere
was chosen so that the distance between every atom in the protein and the
boundary of the water droplet was at least 12 A˚. Each fully solvated system
was energy-minimized using 100 steps of steepest descent, followed by
4900 steps of the conjugate gradient method.
MD simulations
For each system (pY317-Shc and Y317-Shc), we performed five indepen-
dent MD simulations, starting from the same initial structure with different
sets of initial velocities of the atoms, to ensure better conformational
sampling. Trajectories were calculated for 10 ns each, and an aggregate of
50 ns was calculated for each system (Fig. 2). All calculations were per-
formed using Amber version 8.0 (20) on a personal computer (Xeon
3.2 GHz), equipped with special-purpose computer boards for MD simula-
tions, i.e., MDGRAPE-3 (21–23). The AMBER2003 molecular mechanical
force field (24) was adapted for biomolecular-dynamics simulations, with
a time step of integration set to 2 fs. All bond lengths involving hydrogen
atoms were constrained to their respective equilibrium values by the
SHAKE method (25). All noncovalent interactions, and van der Waals
and Coulomb forces and energies, were calculated directly and accurately
(i.e., without specifying any cutoff distance), owing to the use of the
MDGRAPE-3 architecture. Long-range electrostatics contributions beyond
the size of the simulation cell were not considered. We use long-range,
nonbonded cutoffs rather than particle-mesh Ewald for computational effi-
ciency in performing dynamics simulations in our 130,000-atom system.
The former approach is satisfactory as long as the parameters for cutoff func-
tions are carefully chosen, as was the case here (26).
Each analyzed system was gradually heated to 300 K during the first
50 ps, at a heating rate of 6 K/ps. Subsequently, the temperature was main-
tained at a constant 300 K by applying the thermostat of Berendsen et al.
(27), with a coupling time constant of 1.0 ps. During all simulations, water
molecules at the boundary of the water droplet were restrained by a soft
harmonic potential (with a spring constant of 1.5 kcal/mol $ A˚2), to prevent
their movement away from the protein.
Calculation of the binding free energies
Although FEP and TI calculations offer the most powerful approach to esti-
mating the absolute free energies of ligand (protein)-protein binding, this
method has the highest computational cost, and has been limited to small
and rigid ligands and single amino-acid mutations (14–16). More recently,
FEP was applied to phosphotyrosine peptide binding to the SH2 domain
of human Lck (17). However, owing to its computationally intensive nature,
the study of a variety of substrates interacting with a receptor system remains
intractable. The MM-PBSA method has been widely applied to the predic-
tion of binding free energies, because it involves a relatively smallerBiophysical Journal 96(6) 2278–2288
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steps.computational cost, making it more tractable when exploring or comparing
several binding interactions (28–30). This method approximates free ener-
gies using the Poisson-Boltzmann continuum representation of a solvent,
together with a surface area-dependent term and molecular mechanics ener-
gies. However, the MM-PBSA approximation can lead to significant differ-
ences between theoretical and experimental free energies, allowing only
qualitative comparisons between calculated values and those obtained
from experiments (recent performances and applications to peptide-peptide
interactions were described elsewhere (28,31–33)). The LIE method
combines the advantages of the low computational cost of the MM-PBSA
method and the high accuracy of the FEP method. The LIE calculations
exploit the electrostatic linear-response approximation to predict the electro-
static contribution to the binding free energy, and an empirical scaling of the
intermolecular van derWaals energies to predict the nonpolar contribution to
the binding free energy (13). Several successful predictions of binding free
energies according to the LIE method were reported (13,34–38).
The LIE method
We considered five EGFR-derived pY-peptides that corresponded to the
following known Shc binding sites: 1), the pY992 site, VADADEpY-
LIPQQ; 2), the pY1086 site, GSVQNPVpYHNQPLN; 3), the pY1114
site, TAVGNPEpYLNTVQ; 4), the pY1148 site, SLDNPDpYQQDFF;
and 5), the pY1173 site, TAENAEpYLRVA. The estimation of binding
free energies for each of these EGFR-derived pY-peptides and the full-
length Y317-Shc or pY317-Shc was performed in two steps. During step 1,
we constructed model docked structures for EGFR-derived peptides with
Y317-Shc and with pY317-Shc, based on published NMR structures of
complexes of the isolated SH2 domain of Shc with the pY-peptide derived
from the T-cell receptor (PDB identification, 1TCE), and the isolated PTB
domain of Shc with a pY-peptide derived from the TRKA receptor (PDB
identification, 1SHC) (39). In step 2, based on the model docked structures
obtained in step 1, we calculated binding free energies using the LIE method.
We also calculated binding affinities (KD) as follows: KD ¼ exp(DG/RT),
where DG is the binding free energy; R ¼ 1.987 (cal K1 mol1), and
T ¼ 300 K. Steps 1 and 2 are detailed below.
Step 1 docking
The docking procedure involved aligning and fitting the coordinates of
Y317-Shc and pY317-Shc structures and those of the EGFR pY-peptides,
respectively, to the coordinates found in the NMR structural complexes ofBiophysical Journal 96(6) 2278–2288the Shc PTB domain complexed with the TRKA pY-peptide, and those of
the Shc SH2 domain complexed with the T-cell pY-peptide (40). In other
words, full-length Shc molecules were structurally aligned with either the
SH2 domain or PTB domain in the two NMR structural complexes. The
coordinates of full-length Y317-Shc and pY317-Shc used in the alignment
procedure were obtained from the Y317-Shc and pY317-Shc simulations.
In particular, the time-averaged coordinates from trajectory 5 for Y317-
Shc (or Y317-Shc_ave5) and the analogous set of coordinates from trajec-
tory 4 of pY317-Shc (or pY317-Shc_ave4) were used in the alignment
(see Fig. 2 and Results for details).
When introducing the EGFR-derived pY-peptides and building the
complex, amino-acid residues in the pY-peptide templates (i.e., the TRKA
pY-peptide in 1SHC or the T-cell pY-peptide in 1TCE) were appropriately
modified (i.e., deleted or replaced) with the corresponding sequence of resi-
dues in each EGFR-derived pY-peptide. The atoms of side chains were
subsequently energy-minimized, and the backbone atoms were held fixed.
Using this procedure, we modeled five structural complexes of the full-
length Y317-Shc molecule with EGFR pY-peptides: pY992, pY1086,
pY1114, pY1148, and pY1173 bound to the PTB domain, and five structural
complexes of the full-length Y317-Shc molecule with the same five
pY-peptides bound to the SH2 domain. To neutralize the net charge of all
systems, counterions were added to the model structures. Because adding
counterions to the system leads to a slower convergence of simulations
(41), we performed additional 2-ns MD simulations for the five solvated
free pY-peptide systems and 25 solvated Shc-pYpeptide complexes, five
pYs each for the SH2 and PTB domains of Y317-Shc, and three pYs for
PTB and two pYs for SH2 in three distinct conformations of pY317-Shc
(Fig. 2), using the same protocol as described above. Trajectories were saved
every 10 ps and used in the energy calculations.
Step 2 docking
The binding free energies were calculated for the model docked structures by
using the LIE method, according to the following equation (13):
DGbind ¼ bD

Vele
 þ aDVvdW þ g: (1)
Here, Vele and VvdW in ensemble brackets are the MD averages of the van
der Waals energies and electrostatic energies involving the ligand-atoms,
respectively, and D denotes differences between these averages in the ligand
(pY-peptide) bound and free states, calculated from the simulated trajecto-
ries. To calculate these energies, we used a cutoff distance of 25.0 A˚.
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gies, respectively, and g is an additional constant to predict absolute binding
free energies. Because the binding free energies DGbind for the isolated PTB
and SH2 domains of Shc and EGFR-derived pY-peptides used in this study
were determined experimentally (39), we were able to determine scaling
parameters a, b, and g in Eq. 1 by using the theoretical values DhVelei
and DhVvdWi, calculated for each of the corresponding pY-peptide-Shc
domain interactions and the experimental values of DGbind. We estimated
the constants a, b, and g by according to a multiple linear regression anal-
ysis. Unknown free energies of binding between the full-length pY317-Shc
and EGFR-derived pY-peptides were predicted using MD simulations and
the same scaling parameters. Here, we assumed that the scaling parameters
a and b were transferable across the isolated SH2 and PTB domains as well
as the full-length Y317-Shc and pY317-Shc systems. This (and a greater)
degree of transferability of the parameters was shown to be appropriate in
previous applications of the LIE method (13,34–38).
For each EGFR-derived pY-peptide, we selected its preferred binding
domain (SH2 or PTB), based on calculated values for free energies. Only
the domain with the lower binding free energy was chosen for further inves-
tigation in the pY317-Shc system (Fig. 2). This analysis showed that the
PTB domain is the preferred domain for pY1086, pY1114, and pY1148,
whereas the SH2 domain binds better to he pY992 and pY1173 sites. This
observation is consistent with the experimental data reported by Zhou
et al. (39). Thus, in further analyses, we only considered the three modeled
structures of the full-length pY317-Shc molecule bound with each of three
pY-peptides (pY1086, pY1114, and pY1148) to the Shc PTB domain, and
the two modeled structures of pY317-Shc bound with each of two pY-
peptides (pY992 and pY1173) to the Shc SH2 domain (Fig. 2). The model
docked structures were solvated, energy-minimized, and equilibrated as
described in ‘‘System setup’’ and ‘‘MD simulations’’.
Thermodynamic integration
To calculate the relative binding free energy of the pY-peptide between
unphosphorylated Shc (Y317-Shc) and phosphorylated Shc (pY317-Shc),
we used the traditional thermodynamic cycle:
where DG1 is the free-energy change as a result of Y317 phosphorylation of
Shc in the unbound state, i.e., the EGFR pY-peptide is in solution and not
bound to the protein, and DG2 is the free energy change as a result of the
Y317 phosphorylation of Shc in the bound state. The terms DG3 and
DG4 represent the pY-peptide free energies of binding to the Y317-Shc
and pY-317-Shc systems, respectively. The relative binding free energy
of the pY-peptide between Y317-Shc and pY317-Shc was calculated as
DDG h DG3  DG4 ¼ DG1  DG2. To compute DG1 and DG2, we
used the TI method (42).
In the TI calculations, the phosphorylation of Y317 (in Shc) was simu-
lated in two alchemical steps: 1), the van der Waals parameters of atoms
are gradually increased (or decreased) in 20 steps (windows), increasing
the l-value from 0 to 1; and 2), the partial charges of atoms are gradually
increased (or decreased) in seven steps (windows), increasing l from 0 to 1.
The system in each window was simulated for 250 ps, and the last 150 ps
of data were used for the calculation of hvH/vli ¼ dG/dl. From Gaussian
quadrature formulas of higher order, DG is approximately calculated as
DG z
P
wihvH/vlili. The combination of wi and li used in this study is
given in Table 4.
In the TI simulations, a time step of integration of 0.5 fs with no
constraints on bond lengths was used. To assess the statistical error further,
we also performed reverse simulations where the pY317 of Shc was mutatedto Y317. For estimation of errors, the trajectories (the last 150 ps) were
divided into five blocks, and an average DG was calculated for each block.
For the TI calculations, we prepared three different conformations (A, B,
and C), corresponding to the initial (l¼ 0) and final (l¼ 1) states. System A
corresponds to unphosphorylated Shc (bound or unbound to the EGFR pY-
peptide), wherein the partial charges and van der Waals radii of the atoms of
the phosphate moiety are set at zero. System B involves quasiphosphory-
lated Shc (bound and unbound to the EGFR pY-peptide), wherein the partial
charges of dummy atoms of the phosphate moiety are set at zero. System C
involves phosphorylated Shc (bound and unbound to the pY-peptide). The
three systems were fully solvated and energy-minimized, and were equili-
brated through protocols similar to those described in System Setup and
Molecular Dynamics. The equilibrated structures of A, B, and C were
used as the initial and final states for TI calculations. These protocols
were also used in our earlier study (43). The results of TI computations
are reported in Tables 4 and 5.
RESULTS
Molecular dynamics
For each system (Y317-Shc and pY317-Shc), we performed
five independent MD simulations to explore the vast confor-
mational space and investigate the effects of Tyr-317 phos-
phorylation on Shc protein dynamics and Shc interactions
(Fig. 2). To elucidate the dynamic properties of unphos-
phorylated and tyrosine-phosphorylated Shc, for each
system (Y317-Shc and pY317-Shc), the five MD trajectories
were combined into one and then subjected to principal
component analysis (PCA). Such analyses project the
dynamics captured in the trajectories onto a reduced dimen-
sionality, and help distill the slow modes captured in the
trajectories. Here we extracted the first two principal compo-
nents (PCs) describing collective motions of the combined
trajectory for each of the two systems. The cumulative
contribution of these two PCs to the overall dynamics was
> 70%. The individual trajectories of each system were
then projected onto the plane formed by the first two PCs,
as shown in Fig. 3.
For unphosphorylated Y317-Shc, the final (equilibrated)
structures obtained from simulations 1, 2, 3, and 5 (Fig. 3,
left) are closely related and similar to one another, whereas
the structure obtained from simulation 4 is an apparent
outlier on the PC1–PC2 plane (Fig. 3). Thus, simulation
trajectories 1, 2, 3, and 5 represent the salient dynamical
behavior of unphosphorylated Shc. The time-averaged coor-
dinates of Y317-Shc in simulation 5 (Y317-Shc_ave5) were
chosen as a representative structure of unphosphorylated
Shc. The differences between final structures obtained in
these simulations were caused by changes in the positions
of loop regions, but not by changes in the structures or rela-
tive positions of domains. For each domain, the averaged
root mean-square deviations (RMSDs) between the final
structures, averaged over a 5–10-ns period, were as low as
1.21 5 0.24 A˚ (Fig. 4). The nature of the dynamics trajec-
tory harvested in simulation 4 is different from the other
four simulations, as indicated by the starkly different trace
of this trajectory in the PC1–PC2 plane (see Fig. 3). TheBiophysical Journal 96(6) 2278–2288
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obtained from MD simulations for Y317-Shc and pY317-
Shc. Five independent simulations 1–5 were performed
with same initial structure (black square) but different
sets of initial velocities, and were combined into one. Eigen
values and vectors were computed for the merged trajec-
tory, which was then subjected to PCA. The x axis shows
the first largest principal component (PC1), and the y
axis shows the second largest principal component
(PC2). For both Y317-Shc and pY317-Shc, simulations
1–5 show the progress of these five independent simula-
tions. The final structures (circled simulation numbers)
show the results obtained after 10-ns simulations. Points
A and B represent (extrema) conformations of pY317-Shc, farthest from the average structure of simulation 4 along PC1. Point C represents an average confor-
mation of Y317-Shc (i.e., averaged over a distinct cluster of conformations) that is farthest from the time-averaged coordinates of simulation 5 along PC1.traces in Fig. 3 indicate that the direction defined by the first
principal component (PC1) vector can be taken as the typical
dynamics of unphosphorylated Shc. On the PC1 axis, we
compared the representative structure, Y317-Shc_ave5,
with the average structure that represents the most distant
conformational cluster (structure C in Fig. 3) from the
average (i.e., Y317-Shc_ave). The comparison showed that
although the positions of several loop regions (especially
the loop involving Tyr-317 in the CH domain) were
different, the structures of all domains and the relative posi-
tions of these domains did not change (Figs. 4 and 5). This
result demonstrates that the typical dynamics of the Y317-
Shc are mainly caused by the fluctuation of loops in the
CH domain (Fig. 5, gray) and by the coupled motion of
the domains, rather than by a positional rearrangement forBiophysical Journal 96(6) 2278–2288each domain (when the domain motion is coupled, the rela-
tive positions of domains show little change).
The nature of the dynamics in the phosphorylated system
is depicted (in reduced dimensionality) in Fig. 3 (right). For
pY317-Shc, the traces on the PC1–PC2 plane indicate that
the final structures are spread widely. As a representative
structure of pY317-Shc, the average structure of pY317-
Shc simulation 4 (pY317-Shc_ave4), as displayed at the
center point on the PC1–PC2 plane, was selected. By
comparing the pY317-Shc_ave4 structure with the two
most distant structures on the PC1 axis (Fig. 3, structures
A and B), we found that in contrast with unphosphorylated
Shc, variations in the relative positions of pY317-Shc
domains contribute to major differences between these
structures (Fig. 6). These results suggest that Tyr-317FIGURE 4 Time-dependent RMSDs of main chain from the initial structure for each Shc domain (PTB, CH, and SH2). Simulations 1–5 indicate the five
independent simulations we performed with different sets of initial velocities. RMSDs of targeted structure from the reference structure were calculated after
fitting the targeted structure to the reference structure by using the equation (1/N[S {Ri – ri}
2])1/2, where Ri and ri are positions of main-chain atom i in the target
and reference structures, respectively.
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the relative positions of Shc domains by reducing their
coupling and disrupting coordinated motion of the domains.
The conclusions that the domain motion of Y317-Shc is
coupled, and that Tyr-317 phosphorylation reduces this
coupling of the domain motion, are consistent with our
previous results (10). Our simulations (aggregates of 50 ns
for each system) are possibly too short to observe a full-scale
conformational change of Shc induced by Tyr-317 phos-
phorylation. Nevertheless, our findings of subtle rearrange-
ments of the relative positions of domains for pY317-Shc
are significant when viewed in the context of other proteins,
where it is appreciated that changes in relative domain posi-
tions are the key dynamic characteristics of conformational
changes. Such changes can be induced not only by phos-
phorylation, but also by ligand-binding (44–46).
Calculations of free energies for Shc binding to
EGFR-derived pY-peptides
To investigate the impact of Tyr-317 phosphorylation, the
free energies of binding between Shc and five EGFR-derived
pY-peptides (pY992, pY1086, pY1114, pY1148, and
pY1173) were calculated by applying the LIE method
together with MD simulations. In Table 1, we report the
calculated and experimental binding free energies and
average interaction energies (kcal/mol) between Y317-Shc
and EGFR pY-peptides for a test set. The error bars were
estimated by dividing the 1 ns of the equilibrated MD trajec-
tory into four blocks (250-ps windows), computing the mean
values in each block, and calculating the standard deviation
FIGURE 5 Comparison of representative average structure Y317-
Shc_ave5 and structure C (Fig. 3), representing extrema conformations in
our trajectories. Tyr-317 is represented by a space-filling model (green).
The color of each domain is the same as in Fig. 1.of the mean values from the four blocks (shown in paren-
theses in Table 1).
For the docking studies of Y317-Shc with EGFR pY-
peptides, we used the representative structure Y317-
Shc_ave5. As an illustration, the docked structures of the
unphosphorylated Y317-Shc/pY1086 complex, for which the
free energies were evaluated, are shown in Fig. 7. Although
the unphosphorylated system explores a vast conformational
space (e.g., compare the structures Y317-Shc_ave5 and C in
Fig. 3, left), we chose to evaluate the free energies for the
representative docked structure Y317-Shc_ave5. This is
because our analysis of domain motion revealed that the
two domains underwent coupled or concerted motions, and
so the conformations of binding sites for the pY peptides
in the SH2 and PTB domains of Y317-Shc are expected
not to be altered to a significant extent between the different
conformations. However, the scenario for the phosphory-
lated system is quite different.
In the case of the phosphorylated system, because our
simulations unveiled large-scale conformational rearrange-
ments of the relative positions of Shc domains after Shc
phosphorylation on the Tyr-317 residue, we surmised that
the differences in conformations explored in the dynamics
of pY317-Shc could potentially affect the free energy of
binding. To gauge the sensitivity of the distinct conforma-
tions on the calculated values of binding free energy, we
evaluated the binding free energies for different template
structures. For the docking studies with pY-peptides, we
used not only the representative pY317-Shc_ave4 structure,
but also structures A and B (Figs. 5 and 6) of pY317-Shc,
representing extrema in terms of conformational fluctuations
(Fig. 3).
The binding free energies for the PTB and SH2 domains
of Y317-Shc and the five EGFR pY-peptides were deter-
mined experimentally (40), which allowed us to use these
systems as a test set to verify the applicability to our systems
of the linear correlation upon which the LIE methodology is
based, and to determine the scaling parameters a, b, and g
(see Methods). We found that the values a ¼ 0.141, b ¼
0.014m and g ¼ 0.0 provide excellent agreement with the
experimental data, with a correlation coefficient of 0.89
(Fig. 8 and Table 1).
The scaling parameters for electrostatic energy, b, were
very small compared with those reported by other groupsFIGURE 6 Comparison of representative average struc-
ture pY317-Shc_ave4 and structures of extrema conforma-
tions A and B (Fig. 3) captured in our simulations. Domain
motions are shown schematically below corresponding
ribbon diagrams. pTyr-317 is represented by a space-filling
model (green). The color of each domain is the same as in
Fig. 1.Biophysical Journal 96(6) 2278–2288
2284 Suenaga et al.TABLE 1 Calculated and experimental binding free energies and average interaction energies (kcal/mol) between Y317-Shc and
pY-peptides in a test set
Y317-Shc* pY-peptide*
pY-peptide hVboundele i hVboundvdW i hVfreeele i hVfreevdWi DGLIEbindy DGexpbindz
pY992 PTB 1584.680 91.294 1553.163 60.284 4.814 (0.321) 4.3
SH2 818.660 98.469 665.080 72.237 5.849 (0.386) 5.3
pY1086 PTB 1061.417 99.823 936.448 71.041 5.808 (0.339) 7.2
SH2 1441.218 108.145 1414.328 77.702 4.669 (0.408) 5.0
pY1114 PTB 1227.725 84.656 894.639 48.404 9.775 (0.441) 9.4
SH2 748.271 96.544 713.710 63.011 5.212 (0.390) 4.9
pY1148 PTB 476.622 139.136 287.952 92.546 9.211 (0.451) 9.2
SH2 461.847 106.133 428.677 78.009 4.430 (0.417) 4.1
pY1173 PTB 874.030 118.241 810.219 90.750 4.770 (0.377) 4.3
SH2 552.377 82.338 466.415 56.517 4.844 (0.354) 5.8
*Vbound and Vfree are ligand-surrounding energies for ligand-bound and ligand-free states, respectively.
yEach 1-ns trajectory (from 1 to 2 ns) was divided into four blocks (250 ps windows), and mean values were calculated for each window. Standard deviations
are shown in parentheses.
zExperimental values are taken from Zhou et al. (39).(bz 0.5) (13,34–38). This difference can be rationalized by
the notion that the values of scaling parameters should
depend on the nature and size of a ligand, i.e., whether it is
a small molecule inhibitor or a protein, the hydrophobicity
of the ligand, and the wideness of the contact surface area
between receptor and ligand. The pY-peptides have wider
contact surfaces at the binding interface with both the PTB
and SH2 domains in Shc (Fig. 9) than the typical ligands
considered in previous studies using the LIE method (38).
This characteristic of a wider molecular surface area at the
binding interface is evident for both Y317-Shc and pY317-
Shc, justifying our rationale that these two systems are
governed by the same set of scaling parameters.
Notably, although the value of b that was determined to
provide the best correlation between calculated and experi-
mental binding free energies is small, this finding does not
imply that the van der Waals contributions override the elec-
trostatics contributions. An examination of Table 1 reveals
that the dominating contribution in the lower of the calcu-
lated binding free energies of each pY peptide binding to
either the SH2 or to PTB domains in Y317 Shc comes in
some cases from van der Waals (e.g., pY992), and in other
cases from electrostatics (e.g., pY1114). Irrespective of the
dominant contributor, the tighter binding scenario of a partic-Biophysical Journal 96(6) 2278–2288ular pY-peptide to either SH2 or PTB as predicted by our
calculations, in all cases we have considered (for Y317-
Shc), matches the experimental trends. This provides strong
validation that our methodologies of using docking,
dynamics simulation, and the calculation of binding free
energies can provide a reliable framework for comparing
such trends between the Y317-Shc and pY317-Shc systems.
The calculated free energies of binding between full-
length pY317-Shc and EGFR pY-peptides are listed in
Table 2. For each system reported in Table 2, 1 ns of the
equilibrated MD trajectory was divided into four blocks
(250-ps windows), and the block mean values were calcu-
lated for each window. The standard deviations of mean
values from the four blocks are shown in parentheses. The
binding affinities (KD) of EGFR pY-peptides for full-length
Y317-Shc and full-length pY317-Shc are compared in Table
3. These KD values were computed using binding free ener-
gies from Tables 1 and 2, along with the standard deviations.
Remarkably, in all cases, the binding affinities of pY-
peptides declined upon Tyr-317 phosphorylation. The p
values calculated by Student’s t test (Table 3) demonstrate
that the differences between Y317-Shc and pY317-Shc
binding affinities are statistically significant (p < 0.01).
These results corroborate our hypothesis that Shc tyrosineFIGURE 7 Space-filling models for docked structures of
Y317-Shc and EGFR-derived pY-peptide (pY1086) bound
to SH2 domain (left) and PTB domain (right). These
docked structures were used for calculations of correspond-
ing binding free energies. The pY-peptide and Tyr-317 are
colored in green and yellow, respectively. The color of
each domain is the same as in Fig. 1.
Phosphorylation Disrupts Shc Binding to EGFR 2285phosphorylation diminishes its affinity for EGFR, and
strengthen a general view that after phosphorylation, a
signaling protein has the potential to alter the binding
affinity to its partner systematically in intracellular-signal
transduction.
Because a central result of this study (i.e., the binding free
energy estimations for phosphorylated versus unphosphory-
lated Shc) is based on the correlation of binding free energy
data obtained from our simulations (LIE) and our experiment
(Fig. 8), we also performed TI simulations (see Methods) to
validate this correlation and, in particular, to check the valid-
ity of a and b values. Importantly, TI simulations directly
yield the free energy of binding of the EGFR pY-peptide
to Y317-Shc, relative to the binding of the same peptide to
pY317-Shc, i.e., the DDG. value (see Methods and Table
5). Because TI simulations are computationally intensive,
we performed TI simulations only for the case of the
EGFR peptide pY1086 binding to the PTB domain of Shc.
We selected a representative structure resulting from the
averaged coordinates of simulation 5 for the Y317-Shc
system (Figs. 3 and 5). Because the conformational changes
in Shc induced by Y317 phosphorylation could not be
captured in our TI simulations (performed using 250-ps
FIGURE 8 Comparison of experimental and calculated free energies of
binding between Y317-Shc and EGFR-derived pY-peptides. MD trajectories for each window; see Methods), the confor-
mation of pY317-Shc was found to be similar to the confor-
mation labeled pY317-Shc_ave4 in Figs. 3 and 6.
From the LIE simulations, the binding free energy of
pY1086 with pY317-Shc relative to that with Y317-Shc is
DDG ¼ 4.903  (6.526) ¼ 1.623 kcal/mol (Tables 2
and 3). For this same system, the DDG computed from TI
simulations (Tables 4 and 5) was437.641 (439.575)¼
1.934 kcal/mol. Hence, the consistency between the results
of the LIE and TI approaches justifies the values of a and b
(Eq. 1) used to establish the correlation in Fig. 8.
DISCUSSION
After phosphorylation by cell-surface receptors, adaptor
proteins become involved in multiple interactions that prop-
agate extracellular signals to downstream effector pathways.
Recent work demonstrated the combinatorial nature of these
interactions, which play critical roles in both the diversity
and specificity of cellular responses (4,47). For instance,
binding of the adaptor protein Shc to activated RTKs and
subsequent Shc phosphorylation send a biochemical message
to Shc signaling partners that recognize a specific phosphotyr-
osine motif in the central CH region of Shc. In the classic
Ras/extracellular signal-regulated kinase (ERK) activation
pathway, phosphorylated Shc bound to the receptor recruits
FIGURE 9 Intermolecular contact surfaces between Shc PTB domain and
pY1114 (A), and Shc SH2 domain and pY1173 (B), represented in terms of
their molecular surface. The averaged structure (during 1–2-ns period) ob-
tained from 2-ns MD simulation is shown in each panel. pY-peptides are
colored orange. Acidic and basic residues are colored red and blue, respec-
tively. Nonpolar and polar residues are colored green and white, respec-
tively.TABLE 2 Calculated binding free energies between pY317-Shc and pY-peptides
pY0992 pY1086 pY1114 pY1148 pY1173
pY317-Shc_ave4 3.401 (0.412) 6.526 (0.545) 9.544 (0.712) 9.228 (0.698) 4.370 (0.488)
Structure A 5.735 (0.500) 4.490 (0.462) 6.608 (0.579) 7.755 (0.613) 4.836 (0.489)
Structure B 3.590 (0.448) 3.712 (0.431) 5.701 (0.522) 7.806 (0.636) 2.105 (0.395)
Average 4.381 (0.456) 4.955 (0.441) 7.201 (0.560) 8.331 (0.604) 3.800 (0.411)
Binding domain SH2 PTB PTB PTB SH2
All values are in kcal/mol. Each 1-ns trajectory (from 1 to 2 ns) was divided into four blocks (250-ps windows), and mean values were calculated for each
window. Standard deviations are shown in parentheses.Biophysical Journal 96(6) 2278–2288
2286 Suenaga et al.TABLE 3 Comparison of calculated KD values for binding of pY-peptides to Y317-Shc or pY317-Shc
Shc pY0992 pY1086 pY1114 pY1148 pY1173
Y317 54.840 (10.521) 58.744 (9.711) 0.076 (0.017) 0.192 (0.045) 295.953 (118.055)
pY317 643.444 (150.634) 245.675 (55.215) 5.678 (1.727) 0.853 (0.288) 1705.140 (352.179)
p values 0.001* 0.002* 0.002* 0.009* 0.001*
Binding domain SH2 PTB PTB PTB SH2
KD values (in mM) were calculated as KD¼ exp(DG/RT), whereDG represents the binding free energies reported in Tables 1 and 2. R¼ 1.987 (cal K1 mol1),
and T ¼ 300 K. Standard deviations are shown in parentheses.
*Statistical significance of differences in KD values between Y317-Shc and pY317-Shc was determined by Student’s t test. Differences are considered statis-
tically significant at p < 0.01.the complex of Grb2 with guanine nucleotide exchange factor
Son of Sevenless (SOS) to the plasma membrane where the
small GTPase Ras is localized. Thus, activation of the
membrane-anchored Ras, which is a gatekeeper for the Raf/
mitogen-activated protein kinase (MEK)/ERK cascade,
depends critically on whether the complex of phosphorylated
Shc with Grb2 and SOS remains bound to a membrane
receptor, such as EGFR, or has moved from the plasma
membrane into the cell interior (48,49). In the cytoplasm, phos-
phorylated Shc can be associated with Grb2-SOS, can engage
other signaling partners, or may be dephosphorylated by phos-
phatases. Importantly, in either scenario, Shc dissociated from
the receptor does not contribute to Ras activation.
How phosphorylation of an adaptor or enzymatic protein
influences its affinity for the receptor is a key question in
many signaling pathways. For instance, our kinetic model
of the EGFR network predicted that the phosphorylation of
Y317 reduces the affinity of Shc for EGFR and facilitates
the dissociation of Shc from the receptor, thus terminating
signaling to Ras (18). Likewise, a kinetic analysis of exper-
TABLE 4 Thermodynamic integration data: wi and li
n ¼ 20* n ¼ 7*
wi
y li
z wi
y li
z
0.00881 0.00344 0.06474 0.02545
0.02030 0.01801 0.13985 0.12923
0.03134 0.04388 0.19092 0.29708
0.04164 0.08044 0.20898 0.50000
0.05097 0.12683 0.19092 0.70292
0.05910 0.18197 0.13985 0.87077
0.06584 0.24457 0.06474 0.97455
0.07105 0.31315
0.07459 0.38611
0.07638 0.46174
0.07638 0.53826
0.07459 0.61389
0.07105 0.68685
0.06584 0.75543
0.05910 0.81803
0.05097 0.87317
0.04164 0.91956
0.03134 0.95612
0.02030 0.98199
0.00881 0.99656
*Number of windows in integration.
ywi values are calculated from Eq. 14 in Hummer and Szabo (53).
zli values are derived from the solutions of Legendre’s polynomial.Biophysical Journal 96(6) 2278–2288imental data obtained in rat hepatocytes suggests that phos-
phorylation of the 85-kDa subunit of phosphatidylinositol
3-kinase decreases its affinity for EGFR (50). Here, we ad-
dressed the question of whether the phosphorylation of
Y317 on full-length p52 Shc reduces its affinity for EGFR.
To this end, we used MD simulations, directly calculating
the binding free energies of Y317-Shc and pY317-Shc for
all EGFR-derived pY-peptides that correspond to Shc binding
sites on the receptor tail.
The simulated systems of fully solvated Shc molecules
include over 130,000 atoms. To specify the initial atom coor-
dinates, we used our theoretical model structures of full-
length Y317-Shc and pY317-Shc derived previously (10).
By assigning five different sets of initial velocities of the
atoms, we sampled a vast conformational space and calcu-
lated the trajectories during 10 ns, resulting in an aggregate
of 50 ns for each full-length system. This allowed us to
obtain the time-averaged coordinates of atoms that precisely
characterized the difference (in structural terms) between
phosphorylated and unphosphorylated Shc proteins on this
timescale. Importantly, the domains of Y317-Shc always dis-
played concerted or coupled motions, whereas these domains
exhibited large-scale conformational rearrangements for the
phosphorylated pY317-Shc protein. These findings allowed
us to conjecture that the free energies of binding of these
domains to the EGFR-derived pY-peptides would be very
different for full-length unphosphorylated and phosphory-
lated Shc molecules. Through the use of previously pub-
lished NMR structures and homology modeling, we were
able to align structures of EGFR-derived pY-peptides with
the binding sites in Y317-Shc and pY317-Shc proteins, to
obtain docked structures of protein-pY-peptide complexes.
By exploiting the LIE method, we computed how the free
energies of Y-peptide-binding to Y317-Shc and pY317-
Shc differ. The free energy results were obtained through
a careful design and comparison of the LIE method and
TABLE 5 Free energy changes as a result of Y317
phosphorylation of Shc in the bound state and in the solution
estimated from TI simulations (kcal/mol)
Forward
integration
Reverse
integration Average
In bound state 436.7155 0.812 438.5665 0.750 437.6415 0.781
In unbound
solution
439.1225 0.719 440.0285 0.665 439.5755 0.692
Phosphorylation Disrupts Shc Binding to EGFR 2287the TI method. The agreement between the two independent
approaches provided an additional check for the consistency
of the computed binding free energies.
Our main biological finding is that in all the EGFR pY
peptides we have considered, the binding affinities for Shc
systematically declined upon Tyr-317 phosphorylation.
Importantly, the differences in KD values between Y317-Shc
and pY317-Shc were statistically significant for all pY-
peptides studied. This result corroborates our hypothesis that
Shc tyrosine phosphorylation diminishes its affinity for EGFR.
Our calculationswereperformedon relatively large systems
(over 130,000 atoms) and were made possible by our special-
purpose computer for molecular simulation, MDGRAPE-3,
which functions with high speed and accuracy (21–23). We
constructed a Peta-floating point number operations per
second (Peta-flops) system, which is a cluster of personal
computers each equipped with MDGRAPE-3, a custom-de-
signed architecture. The Peta-flops system is a powerful
computer system not only for long-timescale singleMD simu-
lations, but also for massive parallel simulations. Thus,
through the use of this technology, the ability to generate
aggregate 50-ns dynamics trajectories for large systems
enabled us to delineate crucial structural differences in
response to molecular signals, e.g., Y317-phosphorylation.
Although the 50–100-ns timescale is short for capturing full-
scale conformational changes in proteins, the systematic
changes captured in the dynamics simulations provide
a view at molecular resolution of the possible nature of such
a conformational change, and help identify key domain
motions that trigger such changes. Because large-scale confor-
mational changes and substrate recognition are key regulatory
elements in cellular signaling, predicting the molecular
contextwhere such regulation operates is crucial for construct-
ing predictive systems-level models of signal transduction.
With the advent of faster computing platforms to perform
such dynamics calculations and improved methods for
sampling large-scale conformational changes (51,52), the
approachwehaveundertaken canbegeneralized and extended
to other systems, and facilitate the true bridging of structural
biology (x-ray crystallography and NMR) and single-mole-
cule methods with studies in cellular signal transduction.
We thank Dr. Y. Ohno, Dr. G. Morimoto, and Dr. T. Narumi for the use of
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through grant CBET-0730955. B.N.K. acknowledges National Institutes
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of the National Heart, Lung, and Blood Institute Exploratory Program in
Systems Biology).
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